HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

EM703

improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts; structure in first source
Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sunazuka, Toshiaki: 4 articles (06/2013 - 06/2004)
2. Azuma, Arata: 3 articles (06/2013 - 06/2004)
3. Omura, Satoshi: 3 articles (06/2013 - 01/2006)
4. Kudoh, Shoji: 2 articles (06/2013 - 01/2006)
5. Inagaki, Hirofumi: 2 articles (06/2013 - 01/2006)
6. Hirata, Yukiyo: 2 articles (06/2013 - 01/2006)
7. Shimizu, Takako: 2 articles (06/2013 - 01/2006)
8. Kawada, Tomoyuki: 2 articles (06/2013 - 01/2006)
9. Matsuda, Kuniko: 2 articles (01/2006 - 06/2004)
10. Sugawara, Isamu: 1 article (06/2013)

Related Diseases

1. Pulmonary Fibrosis (Hamman Rich Syndrome)
2. Inflammation
3. Lung Injury
4. Lung Diseases (Lung Disease)
5. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. Bleomycin (Blenoxane)
2. Erythromycin (Erycette)
3. Transforming Growth Factor beta (TGF-beta)
4. Cytokines
5. 1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)